Predicting clinically significant prostate cancer following suspicious mpMRI: analyses from a high-volume center.
Matthias JahnenTanja HauslerValentin H MeissnerDonna P AnkerstMichael W KattanAndreas SauterJuergen E GschwendKathleen HerkommerPublished in: World journal of urology (2024)
mpMRI findings are the dominant predictor for csPCa on follow-up prostate biopsy. However, PSA density, age, and prior negative biopsy history are independent predictors. They must be considered when discussing the individual risk for csPCa following suspicious mpMRI and may help facilitate the further diagnostical approach.